Fatal aplastic anaemia associated with clopidogrel

Lancet

Volumn 357, Issue 9254, 2001, Pages 446-

  Trivier, Jean Marc ^a   Caron, Jacques ^c   Mahieu, Michel ^b   Cambier, Nathalie ^b   Rose, Christian ^b  

^a CH Saint Vincent   (France)

^b CH Saint Vincent   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FELODIPINE; FOSINOPRIL; FUROSEMIDE; MOLSIDOMINE; POTASSIUM CHLORIDE; RILMENIDINE; TICLOPIDINE;

AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CASE REPORT; DRUG FATALITY; ERYTHROCYTE TRANSFUSION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PANCYTOPENIA; PRIORITY JOURNAL;

EID: 0035835460     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04015-0     Document Type: Article

References (5)

1. Comparative safety and tolerability of clopidogrel and aspirin: Results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischaemic events
2. Aplastic anaemia and other types of bone marrow failure
3. Ticlopidine and clopidogrel
4. CAPRIE trial
5. Fatal aplastic anaemia associated with lisinopril